.

Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Farmers Insurance
AstraZeneca
Cantor Fitzgerald
US Department of Justice
UBS
Moodys
US Army
Federal Trade Commission
Express Scripts

Generated: December 13, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 070098

« Back to Dashboard

NDA 070098 describes METHYLDOPA, which is a drug marketed by Accord Hlthcare, Duramed Pharms Barr, Halsey, Ivax Sub Teva Pharms, Mylan, Par Pharm, Parke Davis, Pliva, Purepac Pharm, Roxane, Sandoz, Sun Pharm Industries, Superpharm, Teva, Watson Labs, Dava Pharms Inc, Abraxis Pharm, Baxter Hlthcare, Hospira, Luitpold, Marsam Pharms Llc, Smith And Nephew, and Teva Parenteral, and is included in ninety-nine NDAs. It is available from ten suppliers. Additional details are available on the METHYLDOPA profile page.

The generic ingredient in METHYLDOPA is methyldopate hydrochloride. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the methyldopate hydrochloride profile page.

Summary for 070098

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 070098

Mechanism of ActionAdrenergic alpha2-Agonists

Suppliers and Packaging for NDA: 070098

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
METHYLDOPA methyldopa TABLET;ORAL 070098 ANDA Teva Pharmaceuticals USA Inc 0093-2931 0093-2931-10 1000 TABLET, FILM COATED in 1 BOTTLE (0093-2931-10)
METHYLDOPA methyldopa TABLET;ORAL 070098 ANDA Teva Pharmaceuticals USA Inc 0093-2931 0093-2931-01 100 TABLET, FILM COATED in 1 BOTTLE (0093-2931-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength250MG
Approval Date:Feb 20, 1986TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cipla
Deloitte
Boehringer Ingelheim
Mallinckrodt
Federal Trade Commission
Colorcon
Express Scripts
Cerilliant
Fish and Richardson
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot